MENU
GANX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Gain Therapeutics (GANX) Ownership - Who owns Gain Therapeutics?
Gain Therapeutics Inc is a biotechnology company developing novel small molecule therapeutics to treat diseases across several therapeutic areas, including, lysosomal storage disorders, central nervous system disorders, metabolic disorders, and oncology... Show more
Profile
Industry
N/A
Address
4800 Montgomery Lane
Phone
+1 301 500-1556
Employees
32
Web
https://www.gaintherapeutics.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
49.26M
P/E Ratio
N/A
Total Cash
9.07M
Projected Growth
N/A
Total Debt
606.86K
Revenue
N/A
Risk (Beta)
0.06
Dividend Yield
N/A
Total Cash/Share
0.26
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
GANX
Capitalization
49.3M
P/E Ratio
N/A
Risk (Beta)
0.06
Dividend Yield
N/A
Total Cash
9.07M
Total Cash/Share
0.26
Total Debt
607K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
5.78M
P/B Ratio
8.61
Cash Flow
N/A
Earnings
-0.83
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
2.88K
Current Ratio
2.22
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-20.26M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-159.74
Shares Held By Institutions
8.38M
Shares Outstanding - Current
34.6M
Total Liabilities
5.84M
Total Volume MTD
N/A
Value
-1
Gain YTD
-33.333
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
4800 Montgomery Lane
Phone
+1 301 500-1556
Employees
32
Web
https://www.gaintherapeutics.com